- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 776.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 775.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 738.08M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $245K |
| Capex | Q1 2026 · Mar 31, 2025 | $422K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$122.29M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$61.17M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $492.22M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $488.18M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $106.52M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $225.27M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $211.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $545.93M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $658.86M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $344.33M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $388.75M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $83.27M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $72.99M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $101.92M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $92.32M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $616.6M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $720.3M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $647.86M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $751.18M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.24 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.24 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $62.59M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $15.59M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $132.62M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $51.27M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$189.42M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$62.91M |